Dosing of Amoxicillin for Community-Acquired Pneumonia
Dosing Recommendations
- The American Thoracic Society and Infectious Diseases Society of America (ATS/IDSA) recommends amoxicillin 1 gram three times daily for healthy outpatients without comorbidities, with strong recommendation and moderate quality evidence 1, 2, 3
- For outpatients with comorbidities, the ATS/IDSA recommends amoxicillin/clavulanate 500/125 mg three times daily, or 875/125 mg twice daily, or 2000/125 mg twice daily, with strong recommendation and moderate quality evidence 1, 2
- When combined with azithromycin, the azithromycin dose should be 500 mg on the first day followed by 250 mg daily, with strong recommendation and moderate quality evidence 1, 2
Resistance Patterns and Considerations
- Macrolide monotherapy should be avoided in areas with pneumococcal resistance to macrolides ≥25%, according to the American Thoracic Society and Infectious Diseases Society of America (ATS/IDSA) 1, 2, 4
- Consider recent antibiotic exposure when selecting treatment, as patients with recent exposure to one class of antibiotics should receive treatment with antibiotics from a different class due to increased risk for bacterial resistance, as suggested by the Praxis Medical Insights 4
Monitoring and Special Populations
- Assess clinical response after 2-3 days of therapy, and if no improvement is seen, consider alternative diagnoses or resistant pathogens, with moderate quality evidence 3, 4
- For patients requiring hospitalization, intravenous formulations may be preferred initially, with moderate quality evidence 3
- For severe pneumonia requiring ICU admission, different regimens may be indicated, with strong recommendation and moderate quality evidence 1, 2, 3